Aluna
Aluna is a digital health platform specializing in intelligent remote monitoring and management of chronic respiratory diseases. The company offers an FDA-cleared portable spirometer, mobile application, and physician portal that enables patients with asthma, COPD, and cystic fibrosis to track lung function measurements, symptoms, medications, and environmental factors while providing clinicians with remote access to patient health data for improved respiratory disease management.
Acquired
Aluna has been acquired
This company is no longer available on our private secondary market.
Overview
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2020
Total Funding
$27M
2 rounds
Funding
Total raised $27M across 2 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 06-25-2026
Latest Round
Type
Series B
Date
January 31, 2023
Amount
$15.3M
Valuation
—
Lead Investors
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| January 31, 2023 | Series B | $15.3M | — | Matrix Partners |
| Seed / Pre-B aggregate | $11.7M | — | Matrix Partners |
Prominent Investors
Leadership
Competitors
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Spirometry Technologies
Providers of digital spirometry and pulmonary function testing devices for respiratory monitoring
iRhythm Technologies
Remote cardiac and wearable monitoring devices, distinct from respiratory focus
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.